Chimeric RNA: DNA TracrRNA Improves Homology-Directed Repair In Vitro and In Vivo

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Small genetic variations cause nearly 90% of human pathogenic mutations.
• Current gene editing methods using CRISPR-Cas9 and ssODNs for small DNA changes often suffer from inefficiency and imprecise repair.
• Efficient correction of these genetic errors is crucial for therapeutic applications.

Purpose of the Study:

• To develop an improved gene editing technology for precise introduction of small genetic alterations.
• To enhance the efficiency and precision of gene editing using CRISPR-Cas9 and ssODN donors.
• To demonstrate the versatility of the developed technology with other gene editing tools.

Main Methods:

• Developed a novel technology by fusing single-stranded oligo deoxynucleotides (ssODNs) to the trans-activating RNA (tracrRNA) component of CRISPR-Cas9.
• Utilized spatiotemporal localization of the ssODN with CRISPR-Cas9 to improve gene alteration.
• Tested the efficacy of the technology in vitro and in vivo.
• Evaluated the enhancement of gene conversion with other gene editing tools, including transcription activator like effector nucleases (TALENs).

Main Results:

• The fused ssODN-tracrRNA system significantly improved the precision and integration of genetic alterations compared to conventional methods.
• Demonstrated increased efficiency of precise gene editing both in vitro and in vivo.
• Showcased successful enhancement of gene conversion with TALENs, indicating broad applicability.

Conclusions:

• The developed technology offers a streamlined and highly precise method for introducing small genetic changes.
• This approach overcomes limitations of current CRISPR-Cas9-mediated gene editing, improving accuracy and efficiency.
• The technology holds significant potential for advancing gene therapy and genetic research by enabling more reliable gene correction.